Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the report by the All-Party Parliamentary Group on Hospice and End of Life Care The Lasting Impact of COVID-19 on Death, Dying and Bereavement, published on 1 March, what assessment they have made of innovations in the administration of palliative care medication that were developed during the COVID-19 pandemic; and what plans they have to roll out any of these innovations more widely.

While no specific assessment of the innovations in the administration of palliative care medication has been made, the Government and NHS England both recognise the importance of timely access to palliative and end of life care medicines for patients and those important to them. Clinicians should provide details of who can administer the medicine, ensuring they follow local guidance and consider national best practice.